Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit Programme - Competition 43 stage 2 and Competition 44 stage 1 Minutes, North West

Contents

Published: 03 August 2021

Version: 1.0 - May 2021

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme  North West Regional Advisory Committee meeting to discuss applications Competition 43 Stage 2 and Competition 44 Stage 1.

Date and Location

Tuesday 18 May 2021 Virtual Meeting

In attendance

Committee Members

Professor Kevin J Munro (Chair)
Professor Katherine Berry
Dr Helen Brooks
Professor Iain Bruce
Dr Elizabeth Camacho
Dr Lesley-Anne Carter
Dr Louise Anne Connell
Mrs Glenys Hunt
Ms Judith Jones
Professor Gregory Lip
Dr Matthew Parkes
Professor Rod Stables
Mr Steve Telford
Dr Laura Ternent
Dr Mark Wilberforce

Secretariat

Mr Charlie Delilkan (NIHR CCF)
Mr Ben Morgan (NIHR CCF)
Dr Ianina Conte (NIHR CCF)
Ms Saida Sherif (NIHR CCF)
Ms Ellie Mitchell  (NIHR CCF)

Observers

Mr Alex Mitchell RDS - YH
Dr Diarmuid.Coughlan RDS - NE

 Apologies were received from Dr Andrew Sharp, Professor Hedley Emsley, Professor Suresh Chhetri and Professor Deborah Fitzsimmons

1. Stage 2 applications considered

1.1 NIHR202832: Developing evidence-based text messages to target diet and physical activity behaviour for people with type 2 diabetes mellitus

Conflicts: Dr Mark Wilberforce, Professor Katherine Berry and Dr Matthew Parkes

Final outcome: Conditional support

1.2 NIHR202817: Assessing the utility and cost-effectiveness of anti-PLA2R for diagnosing patients with membranous nephropathy in clinical practice: a systematic review and evidence synthesis study

Conflicts: Professor Iain Bruce

Final outcome: Conditional support

1.3 NIHR202782: Improving patient outcomes post pelvic radiotherapy: developing a patient-reported outcome measure for clinical use and for the evaluation of complex interventions (RadBonePROM)

Conflicts: Dr Helen Brooks and Dr Elizabeth Camacho

Final outcome: Reject

1.4 NIHR202773: Exercise as medicine in oncology: a feasibility study investigating a patient-centred approach to exercise for head and neck cancer survivors

Conflicts: Professor Louise Connell, Dr Diarmuid.Coughlan (observer) and Dr Laura Ternent

Final outcome: Conditional support

1.5 NIHR202808: Monitoring for melanoma relapse using circulating tumour DNA blood tests: what is the patient experience?

Conflicts: Professor Katherine Berry

Final outcome: Reject

1.6 NIHR202836: DIPP study: Development and Impact of guidelines, decision-tools and training in the diagnosis and referral of patients with Papilloedema versus Pseudopapilloedema

Conflicts: None

Final outcome: Reject 2. 

2. Stage 1 applications considered

2.1 NIHR203036: Empowering Bladder Cancer Patients by Developing a Nationwide and Tailored Wellbeing Information Resource

Conflicts: None

Outcome: Reject

2.2 NIHR203173: VAlidation of the Mcast CommunicAtion Screening Tool (VAMCAST): improving patient access to communication support during mental capacity assessments

Conflicts: None

Outcome: Invite to Stage 2

2.3 NIHR203044: Mapping Integration and Development of Oral Health Interventions for the Liver Cirrhosis Care Pathway MODEL study

Conflicts: None

Outcome: Reject

2.4 NIHR203051: A feasibility trial of remotely-delivered Video Interaction Guidance [VIG] for families of children with a learning disability referred to specialist mental health services

Conflicts: Professor Louise Connell

Outcome: Invite to Stage 2

2.5 NIHR203154: Testing the Fear of Childbirth Questionnaire and feasibility of routine implementation for maternity services

Conflicts: Professor Rodney Stables, Professor Louise Connell and Professor Katherine Berry

Outcome: Invite to Stage 2

2.6 NIHR203046: Development of an optimal physiotherapy intervention for arthrofibrosis following total knee replacement

Conflicts: None

Outcome: Invite to Stage 2

2.7 NIHR203188: Problems with sleep environments on inpatient mental health wards, and staff and patients' views on possible solutions: a mixed methods intervention development study

Conflicts: Professor Katherine Berry, Dr Elizabeth Camacho, Dr Helen Brooks and Dr Lesley-Anne Carter

Outcome: Invite to Stage 2

2.8 NIHR203207: Identifying and Addressing Cardiovascular Medication Nonadherence in Type 2 Diabetes using Urinalysis and a Discussion Tool: A Feasibility Study

Conflicts: Professor Gregory Lip and Mr Alex Mitchell (observer)

Outcome: Invite to Stage 2

2.9 NIHR203118: Exploring systemic therapy as post-diagnostic support for people living with dementia and their families

Conflicts: Professor Katherine Berry

Outcome: Reject

2.10 NIHR203114: Validation of the risk stratification tool for premature mortality and preventable deaths in people with intellectual disability

Conflicts: None

Outcome: Reject

2.11 NIHR203093: Evaluating use of Novel Handheld Artificial intelligence algorithm for skin Cancer Examination (ENHANCE) - a feasibility and mixed methods study investigating the impact of the introduction of artificial intelligence to help primary care skin cancer diagnosis and referral

Conflicts: Professor Katherine Berry, Dr Matthew Parkes, Dr Elizabeth Camacho and Dr Lesley-Anne Carter

Outcome: Reject 

Outcomes tables

The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.

In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.

Stage 1

ScoreRangeNumber of applications
9-10 Invited  0
8 Invited  0
7 Invited 1
6 Invited 5
5 Rejected 4
4 Rejected 0
3 Rejected 1
2 Rejected 0
1 Rejected 0

Stage 2

ScoreRangeNumber of applications
9-10 Fundable 0
8 Fundable 1
7 Fundable 1
6 Fundable 1
5 Rejected 3
4 Rejected 0
3 Rejected 0
2 Rejected 0
1 Rejected 0